P/E ratio for Helius Medical Technologies (HSDT)
P/E ratio as of April 2024 (TTM): -0.2045
According to Helius Medical Technologies's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.204545. At the end of 2022 the company had a P/E ratio of -0.0025.
P/E ratio history for Helius Medical Technologies from 2014 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.0025 | -81.47% |
| 2021 | -0.0137 | -33.58% |
| 2020 | -0.0207 | -60.52% |
| 2019 | -0.0524 | -64.51% |
| 2018 | -0.1477 | -11.26% |
| 2017 | -0.1665 | -21.46% |
| 2016 | -0.2120 | -2.87% |
| 2015 | -0.2182 | -36.71% |
| 2014 | -0.3448 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 ReWalk Robotics RWLK | -3.18 | 1,455.71% | 🇮🇱 Israel |
 Orthofix Medical
OFIX | -3.55 | 1,636.49% | 🇺🇸 USA |
 Axogen AXGN | -11.8 | 5,670.66% | 🇺🇸 USA |
 Qiagen QGEN | 28.6 | -14,090.71% | 🇳🇱 Netherlands |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.